LATEST ARTICLES
  • Thermo Fisher to buy research contractor PPD in $17B deal
  • Cancer biotech Tango to go public through $350M SPAC deal
  • Sage, Biogen drug reduces tremors but side effects could limit potential
  • GSK stops studies testing closely watched cancer immunotherapy
  • Moderna watches for ‘waning immunity’ as new data show durable vaccine protection
  • Merck, in latest COVID-19 setback, scraps one drug and pins hopes on another
  • Lilly claims promising finding in failed study of COVID-19 drug
  • With new data, Merck could be first to bring immunotherapy to early kidney cancer
  • Biogen adds a late-stage prospect to its growing biosimilar business
  • Gilead wins full approval for drug acquired in Immunomedics deal
  • Home
  • CURRENT FEATURES
  • Editorial Archive
    • Volume 3 Issue 3
    • Volume 3 Issue 2
    • Volume 3 Issue 1
    • Volume 2 Issue 4
    • Volume 2 Issue 3
    • Volume 2 Issue 2
    • Volume 2 Issue 1
    • Volume 1 Issue 3
    • Volume 1 Issue 2
    • Volume 1 Issue 1
  • ARCHIVED ISSUES
  • Events
  • Company Profile
  • Sponsored Articles
  • news
    • Clinical Trials Advisor
    • Drug Industry Daily
    • Drug GMP Report
    • Manufacturing & Packaging
    • Discovery & Development
  • eBooks
  • Podcast
Search
Close
  • Home
  • CURRENT FEATURES
  • Editorial Archive
    • Volume 3 Issue 3
    • Volume 3 Issue 2
    • Volume 3 Issue 1
    • Volume 2 Issue 4
    • Volume 2 Issue 3
    • Volume 2 Issue 2
    • Volume 2 Issue 1
    • Volume 1 Issue 3
    • Volume 1 Issue 2
    • Volume 1 Issue 1
  • ARCHIVED ISSUES
  • Events
  • Company Profile
  • Sponsored Articles
  • news
    • Clinical Trials Advisor
    • Drug Industry Daily
    • Drug GMP Report
    • Manufacturing & Packaging
    • Discovery & Development
  • eBooks
  • Podcast

Header Banner

IBI-white
Facebook
Twitter
Tumblr
  • About Us
  • Author Guidelines
  • Peer-Review Protocol
  • Advertise With Us
    • Media Information 2021
  • Subscribe
  • Contact Us
Bio Pharmaceutical Media © 2021, All Rights Reserved – Powered by Teksyte